Last deal

$2.16M

Amount

Angel

Stage

12.07.2017

Date

3

all rounds

$2.58M

Total amount

date founded

Financing round

General

About Company
TypeZero Technologies revolutionizes diabetes treatment with digital health and personalized medicine.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2013

Number of employees

Company Type

For Profit

Last funding type

Angel

IPO status

Private

Description

The company's inControl Diabetes Management Platform includes advisory applications for smart insulin pens and smartphone-based artificial pancreas systems that automatically regulate insulin delivery, drastically reduce hypoglycemia, and significantly improve blood glucose levels. TypeZero is combining next-generation data science techniques, proven metabolic models, and modern engineering practices to develop customized analytics tools and blood glucose control solutions to help people with type 1 and type 2 diabetes improve their health and lives.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
HYGIEIA

HYGIEIA

Heggieia's d-Nav® Insulin Management System helps people with Type 2 diabetes use insulin safely and effectively.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Ann Arbor, MI, USA

total rounds

14

total raised

$52.29M
DreaMed Diabetes

DreaMed Diabetes

DreaMed Diabetes provides personalized diabetes treatment optimization solutions.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Artificial Intelligence, Medical Device

Location

Petah Tikva, Israel

total rounds

4

total raised

$13.3M

LXN Corporation

LXN Corporation is a medical technology company that develops and markets products to help people with diabetes manage their disease.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Medical
Diabnext

Diabnext

Diabnext is a digital diabetes management app that automates insulin and blood glucose monitoring.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Artificial Intelligence, Software

Location

Paris, France
M&A Details
1

Transaction name

Acquired by

Dexcom

announced date

22.08.2018

Financials

Funding Rounds
3
3

Number of Funding Rounds

$2.58M

Money Raised

Their latest funding was raised on 12.07.2017. Their latest round Angel

Date 
Funding Round 
Investors 
Money Raised 
Lead 
12.07.2017
$2.16M
01.07.2016
1
24.06.2015
1
$415K
Co-Investors
Investors
2
0

Number of lead investors

2

Number of investors

Investor 
Lead 
Round 
Partners 

UVA Licensing & Ventures Group

The UVA Fund is a venture capital firm based in Charlottesville, Virginia.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Charlottesville, VA, USA

count Of Investments

15

count Of Exists

2
CIT GAP Funds

CIT GAP Funds

The Virginia Venture Capital Corporation (VVC) is a non-profit organization that drives innovation and entrepreneurship in Virginia.

Sector

Industrial Support Services

Subsector

Professional Business Support Services

Keywords

Non-Profit, Venture Capital, Financial Services

Location

Herndon, VA 20170, USA

count Of Investments

194

count Of Exists

36

People

Founders
3
Marc Breton
Marc Breton

Marc Breton

Marc Breton is an Associate Professor at the University of Virginia & Co-Founder of TypeZero Technologies LLC. He attended University of Virginia.

organization founded

1

Marc Breton

Chad Rogers
Chad Rogers

Chad Rogers

current job

Black Tie Ski Rentals of Jackson Hole

organization founded

1

Chad Rogers

Patrick Keith-Hynes
Patrick Keith-Hynes

Patrick Keith-Hynes

current job

TypeZero Technologies
TypeZero Technologies

organization founded

1

Patrick Keith-Hynes

Employee Profiles
7
Boris Kovatchev

Boris Kovatchev

Co-founder and Chief Mathematician

Patrick Keith-Hynes

Patrick Keith-Hynes

CTO & Founder

Chad Rogers

Chad Rogers

Founder & CEO

Activity

Recent News
0